Gyre Therapeutics, Inc. Payments for (Proceeds from) Investments
Gyre Therapeutics, Inc. (GYRE) reported Payments for (Proceeds from) Investments of -$36.94 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2013-08-07
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for the quarter ending 2013-06-30 was -$20.48M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for the quarter ending 2013-03-31 was -$16.46M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for the quarter ending 2012-12-31 was -$30.25M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for the quarter ending 2012-09-30 was -$45.38M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for fiscal 2012 was -$159.54M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for fiscal 2011 was -$100.01M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for fiscal 2010 was -$84.48M.
- Gyre Therapeutics, Inc. payments for (proceeds from) investments for fiscal 2009 was -$41.00M.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$20.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$36.94M 10-Q · filed 2013-08-07 | -$67.19M derived: sum of 3 quarters · filed 2013-08-07 | -$112.57M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | -$16.46M 10-Q · filed 2013-05-08 | -$46.71M derived: sum of 2 quarters · filed 2013-05-08 | -$92.08M derived: sum of 3 quarters · filed 2013-05-08 | -$127.24M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | -$30.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$75.63M derived: sum of 2 quarters · filed 2013-03-15 | -$110.78M derived: sum of 3 quarters · filed 2013-08-07 | -$159.54M 10-K · filed 2013-03-15 |
| 2012-09-30 | -$45.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$80.53M derived: sum of 2 quarters · filed 2013-08-07 | -$129.29M 10-Q · filed 2012-11-08 | -$168.06M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | -$35.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$83.91M 10-Q · filed 2013-08-07 | -$122.68M derived: sum of 3 quarters · filed 2013-08-07 | -$138.94M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | -$48.75M 10-Q · filed 2013-05-08 | -$87.52M derived: sum of 2 quarters · filed 2013-05-08 | -$103.78M derived: sum of 3 quarters · filed 2013-05-08 | -$124.50M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | -$38.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$55.03M derived: sum of 2 quarters · filed 2013-03-15 | -$75.75M derived: sum of 3 quarters · filed 2013-03-15 | -$100.01M 10-K · filed 2013-03-15 |
| 2011-09-30 | -$16.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$36.98M derived: sum of 2 quarters · filed 2012-11-08 | -$61.24M 10-Q · filed 2012-11-08 | -$71.88M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$20.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$44.98M 10-Q · filed 2012-08-09 | -$55.62M derived: sum of 3 quarters · filed 2013-03-15 | -$83.96M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$24.26M 10-Q · filed 2012-05-09 | -$34.90M derived: sum of 2 quarters · filed 2013-03-15 | -$63.24M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | -$10.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$38.98M derived: sum of 2 quarters · filed 2013-03-15 | -$84.48M 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$28.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$73.84M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$45.50M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$41.00M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |